Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Klotho Neurosciences Inc (NASDAQ: KLTO) closed at $0.18 in the last session, down -4.96% from day before closing price of $0.19. In other words, the price has decreased by -$4.96 from its previous closing price. On the day, 0.61 million shares were traded.
Ratios:
We take a closer look at KLTO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.29. In the meantime, Its Debt-to-Equity ratio is 2.77 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 02 ’24 when CHARDAN CAPITAL MARKETS LLC sold 180,000 shares for $2.05 per share. The transaction valued at 368,442 led to the insider holds 1,284,364 shares of the business.
CHARDAN CAPITAL MARKETS LLC sold 115,136 shares of KLTO for $237,618 on Jul 01 ’24. The 10% Owner now owns 1,464,364 shares after completing the transaction at $2.06 per share. On Jun 28 ’24, another insider, CHARDAN CAPITAL MARKETS LLC, who serves as the 10% Owner of the company, sold 47,000 shares for $2.53 each. As a result, the insider received 119,103 and left with 1,579,500 shares of the company.
Stock Price History:
Over the past 52 weeks, KLTO has reached a high of $8.11, while it has fallen to a 52-week low of $0.11. The 50-Day Moving Average of the stock is -6.15%, while the 200-Day Moving Average is calculated to be -59.60%.
Shares Statistics:
A total of 28.51M shares are outstanding, with a floating share count of 26.77M. Insiders hold about 17.63% of the company’s shares, while institutions hold 2.60% stake in the company.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
